Catalyst Wire Dossier Catalyst Wire Dossier

ASP3652

· Astellas Pharma Europe B.V.
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for ASP3652, covering 2013-02-22 to 2024-11-05. Get the full timeline:

Most recent: Clinical Trial Update: A Randomized Study Comparing Placebo and ASP3652 in the Treatment of Women With Bladder Pain Syndrome / Interstitial Cystitis (BPS/IC) [Phase 2]

See pricing